View Expired Tender

Get immediate access to tenders like the one below by subscribing now to Tenders Direct. We will set up your personalised profile and send you tender alerts direct to your mailbox as soon as they are published. You will also benefit from having access to historical tenders.

Notice Summary

United Kingdom-London: Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables
396491-2019
University College London Hospitals NHS Foundation Trust (UCLH)
22 August 2019
16 September 2019
Contract Notice - Competitive procedure with negotiation
Yes

Notice Abstract

University College London Hospitals NHS Foundation Trust is looking to establish a single supplier framework agreement to deliver a fully integrated radiopharmacy services and consumables. The framework agreement will consist of 3 lots:— Lot 1: UCLH Managed Services,— Lot 2: Managed Services,— Lot 3: Radiopharmaceutical Consumables.

Notice Details

Contract notice

Directive 2014/24/EU - Public Sector Directive

Directive 2014/24/EU

Section I: Contracting Change entity

I.1) Name and addresses

University College London Hospitals NHS Foundation Trust (UCLH)

235 Euston Road, Bloomsbury

London

NW1 2BU

UK

E-mail: samm.parker1@nhs.net

NUTS: UK

Internet address(es)

Main address: http://www.uclh.nhs.uk

Address of the buyer profile: http://www.uclh.nhs.uk

I.2) Joint procurement

The contract is awarded by a central purchasing body

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://www.lppsourcing.org


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://www.lppsourcing.org


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables

Reference number: DN426162

II.1.2) Main CPV code

85149000

 

II.1.3) Type of contract

Services

II.1.4) Short description

University College London Hospitals NHS Foundation Trust is looking to establish a single supplier framework agreement to deliver a fully integrated radiopharmacy services and consumables. The framework agreement will consist of 3 lots:

— Lot 1: UCLH Managed Services,

— Lot 2: Managed Services,

— Lot 3: Radiopharmaceutical Consumables.

II.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

Maximum number of lots that may be awarded to one tenderer: 3

II.2) Description

Lot No: 1

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

University College London Hospitals NHS Foundation Trust (the ‘Authority’), is issuing this tender in connection with a competitive with negotiation procedure procurement for the provision of a framework agreement for nuclear medicine radiopharmacy services and consumables for University College London Hospitals NHS Foundation Trust (the ‘Contract’), and the subsequent call-off of Radiopharmacy Services and Consumables (the ‘Call-Offs’) from the Contract by the Authority.

This procurement and resulting single supplier framework agreement contains 3 lots:

Lot 1: UCLH Managed Services;

Lot 2: Managed Services;

Lot 3: Radiopharmaceutical Consumables.

The highest scoring supplier will be awarded all 3 lots, resulting in a single supplier framework agreement. Where the Authority wishes to call-off from this framework agreement, a separate Contract will be entered into for the services under each lot.

Where the Authority wishes to call-off from this framework agreement, a separate Contract will be entered into for the services under each lot. The framework agreement will be available to the Authority and all other NHS Trusts. For a detailed list of all NHS Trusts please see https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx

UCLH provides first-class acute and specialist services in 6 hospitals in central London.

Our mission is to deliver top-quality patient care, excellent education and world-class research.

In partnership with University College London (UCL) we are 1 of the country’s 5 comprehensive biomedical research centres. We are a member of UCL partners which brings together some of the UK's world-renowned medical research centres and hospitals.

UCLH employs over 8 800 staff, has approximately 1 161 beds across all its sites with approximately 160 000 inpatient admissions and 950 000 outpatient appointments per annum.

During 2019 and 2020 UCLH will be opening 2 new hospital sites:

— opening in September 2019, a specialist centre for services currently at the Eastman Dental and Royal National Throat Nose and Ear Hospitals,

— opening in 2020, a new facility which includes Europe’s largest centre for blood disorders, short stay surgery and a national proton beam therapy centre.

Further information relating to the non-PFI estate can be found in the data pack issued with this ITPN and in the service matrix.

The Institute of Nuclear Medicine (INM) carries out radionuclide imaging investigations and therapies for the purposes of clinical diagnosis, treatment and research. It is the largest single site department in the UK and currently undertakes some 17 000 studies per annum.

INM provide a wide range of ‘state of the art’ nuclear medicine imaging services including:

— general nuclear medicine including in-vitro tests,

— Single-Photon Emission Computed Tomography (SPECT)/with x-ray Computed Tomography (CT) (SPECT/CT),

— ultra-fast dedicated cardiac SPECT,

— Positron Emission Tomography/Computed Tomography (PET/CT),

— Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) (first in the UK).

In addition, INM also perform a range of routine and experimental inpatient and outpatient radionuclide therapy procedures, with access to 10 dedicated radionuclide therapy beds.

The Authority is looking to enter into a new Contract that is able to provide an innovative and flexible approach.

It is seen as imperative that there is an on-site element to this Contract in order to maintain an efficient and effective working partnership with tangible benefits for both parties. In particular certain isotopes would continue to benefit form on site production due to their limited shelf life.

II.2.5) Award criteria

Criteria below:

Quality criterion: Quality / Weighting: 60 %

Price / Weighting:  40 %

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 120

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

Objective criteria for choosing the limited number of candidates:

Suppliers are to refer to the SQ (supplier questionnaire) which includes project specific questions.

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents


III.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Competitive procedure with negotiation

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement with a single operator.

Justification for any framework agreement duration exceeding 8 years: Due to the capital equipment costs and potential works, this framework will exceed 4 years.

IV.1.5) Information about negotiation

The contracting authority reserves the right to award the contract on the basis of the initial tenders without conducting negotiations

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 16/09/2019

Local time: 10:00

IV.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates

Date: 30/09/2019

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.4) Procedures for review

VI.4.1) Review body

University College London Hospitals NHS Foundation Trust

London

UK

VI.4.3) Review procedure

Precise information on deadline(s) for review procedures:

In accordance with Regulation 86 (notices of decisions to award a Contract) Regulation 87 (Standstill Period) and Regulations 91 (Enforcement of duties through the Court) of the Public Contracts Regulations 2015 (as amended).

VI.5) Date of dispatch of this notice

19/08/2019